Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Organovo Holdings, Inc. (NASDAQ: ONVO).

Full DD Report for ONVO

You must become a subscriber to view this report.


Recent News from (NASDAQ: ONVO)

New Research Coverage Highlights Tyson Foods, Windstream, Laredo Petroleum, Idera Pharmaceuticals, Diamondrock Hospitality, and Organovo - Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, May 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Tyson Foods, Inc. (NYSE:TSN), Windstream Holdings, Inc. (NASDAQ:WIN), Lare...
Source: GlobeNewswire
Date: May, 16 2018 07:55
Organovo Announces Release Date for Fiscal Fourth-Quarter 2018 Financial Results
SAN DIEGO, May 14, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, May 31, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal fourth-quarter 2018 financial results. In advance of the call on ...
Source: GlobeNewswire
Date: May, 14 2018 08:05
Organovo to Present New Preclinical Data for Its Liver Therapeutic Tissue IND-Track Programs at the World Advanced Therapies and Regenerative Medicine Congress
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it will present new preclinical data showing the strong functionality of its liver therapeutic tissue in a second IND-track program for Type 1 Tyrosinemia.&...
Source: GlobeNewswire
Date: May, 10 2018 08:05
Organovo joins institute dedicated to developing manufacturing processes for regenerative therapies
Organovo Holdings ( ONVO ) announces that it has joined a new public-private organization, the Advanced Regenerative Manufacturing Institute (ARMI), a consortium of almost 100 groups from industry, government, academia and the non-profit arena, to develop next-generation manufacturing proc...
Source: SeekingAlpha
Date: May, 03 2018 09:34
Organovo and Samsara Sciences Partner with New Manufacturing USA Institute
SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced it has joined a new public-private Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute (“ARMI”).  Headquartered in...
Source: GlobeNewswire
Date: May, 03 2018 08:05
Organovo to Present at 2nd Annual NASH Summit
SAN DIEGO, April 24, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it will present at the 2nd Annual NASH Summit in Boston, Ma. on Tuesday, April 24th at 4:00pm ET. Alice Chen, Director of Tissue Applications at Orga...
Source: GlobeNewswire
Date: April, 24 2018 08:05
Organovo Achieves Key Development Milestones for Its Liver Disease and Intestinal Tissue Models
SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that along with its collaborators, it has achieved several breakthrough capabilities for its 3D bioprinted tissues.  At last week’s International L...
Source: GlobeNewswire
Date: April, 16 2018 08:05
3 Things In Biotech, April 14: Organovo, Catalyst, And Aeglea Open Up
Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we're talking about! Welcome to another edition of "3 Things In Biotech," a daily digest dedicated to helping you keep pace with the fast-moving worl...
Source: SeekingAlpha
Date: April, 15 2018 08:00
Organovo Presents Data on Modeling Liver Disease Using 3D Bioprinted Human Liver Tissue at The International Liver Congress(TM)
SAN DIEGO, April 12, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today presented data on modeling non-alcoholic fatty liver disease (“NAFLD”) using its 3D bioprinted human liver tissues.  This data was presented at The In...
Source: GlobeNewswire
Date: April, 12 2018 08:05
Cirius Therapeutics' Preclinical Data Demonstrates Potential for Lead Drug Candidate MSDC-0602K in NASH
SAN DIEGO and KALAMAZOO, Mich. , April 12, 2018 /PRNewswire/ -- Cirius Therapeutics announced today that it presented a late-breaking poster describing the activity of the company's lead drug MSDC-0602K in a three-dimensional bioprinted human tissue model of NASH at The Internation...
Source: PR Newswire
Date: April, 12 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-141.101.121.131.05729,015
2018-08-131.121.081.1391.08594,758
2018-08-101.331.141.341.101,556,300
2018-08-091.301.371.381.2974702,748
2018-08-081.231.2951.321.22524,379

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-14169,904332,64651.0765Short
2018-08-13120,563281,64642.8066Short
2018-08-10367,028668,74954.8828Short
2018-08-09180,664293,12361.6342Short
2018-08-08130,666240,14254.4120Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ONVO.


About Organovo Holdings, Inc. (NASDAQ: ONVO)

Logo for Organovo Holdings, Inc. (NASDAQ: ONVO)

Organovo designs and creates functional human tissues using a proprietary three dimensional bioprinting technology. The Company focuses on developing a range of human tissues and disease models for medical research and therapeutic applications. The Company s NovoGen three dimensional bioprinting technology employs a specialized automated platform that works across all tissue and cell types. Organovo s bioprinter was named one of the Best Inventions of by TIME Magazine and Organovo has been recognized as one of the most innovative companies of by MIT s Technology Review. Organovo is helping pharmaceutical partners develop never before available human biological disease models in three dimensions that hold the potential to transform the business of therapeutic drug discovery and development. Organovo is also developing direct tissue therapies where precise structure and architecture may deliver the best clinical outcomes. Organovo leads the way in solving complex medical research problems and building the future of medicine.

 

Contact Information

 

 

Current Management

  • Keith Murphy / CEO, President
  • Barry D. Michaels / CFO, Corporate Secretary
  • Michael Thomas Renard / EVP
  • Eric Michael David / CSO
  • Sharon Collins Presnell / CTO
  • Keith Murphy / Chairman
  • Andras Forgacs /
  • James T. Glover /
  • Tamar D. Howson /
  • Robert Baltera, Jr. /
  • Adam K. Stern /

Current Share Structure

  • Market Cap: $162,928,880 - 05/11/2018
  • Authorized: 150,000,000 - 02/03/2012
  • Issue and Outstanding: 110,835,973 - 02/01/2018
  • Float: 50,000,000 - 03/31/2013

 


Recent Filings from (NASDAQ: ONVO)

Filing Type: CT ORDERFiling Source: edgar
Filing Date: May, 17 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: March, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 16 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: March, 16 2018
Post-effective amendment to an S-Type filing
Filing Type: POS AMFiling Source: edgar
Filing Date: March, 16 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 08 2018
Simplified registration form
Filing Type: S-3Filing Source: edgar
Filing Date: February, 08 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 29 2018

 

 


Daily Technical Chart for (NASDAQ: ONVO)

Daily Technical Chart for (NASDAQ: ONVO)


Stay tuned for daily updates and more on (NASDAQ: ONVO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ONVO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ONVO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of ONVO and does not buy, sell, or trade any shares of ONVO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/